Samuel A. Shelburne, MD
Disclosures: Nothing to disclose - 06/07/2021

Samuel Shelburne, MD, PhD is a currently a Professor in the Departments of Infectious Diseases and Genomic Medicine at MD Anderson Cancer Center.  He received his undergraduate degree in Art History from Princeton University and his MD from the University of Texas Medical Branch at Galveston.  He did his Internal Medicine residency and Infectious Diseases fellowship at Baylor College of Medicine where he also obtained a PhD in clinical investigation.  His clinical work at MD Anderson focuses on the treatment and prevention of infections in patients with leukemia.  The research in Dr. Shelburne’s laboratory focuses on understanding the molecular basis of bacterial infections in humans.  Large scale genomic sequencing of clinical isolates are also used to explore epidemiology, antimicrobial resistance, and clinical outcome heterogeneity in medically important bacterial pathogens such as group A and B Streptococcus, viridans group streptococci, and Enterobacteriaceae. Finally, the laboratory seeks to understand how host genetics, microbiome, and pathogen genetics contribute to susceptibility and infection outcomes in patients with malignancy.